Aimo Kannt
Papers
1
Total Citations
8
H-Index
1
About
Aimo Kannt is a leading researcher whose work bridges molecular biochemistry and clinical nephrology, with a primary focus on diabetic kidney disease (DKD) and the role of the enzyme carnosinase 1 (CN1). His key research areas include the pathophysiology of type 2 diabetes complications, biomarker discovery, and the enzymatic mechanisms underlying renal function decline. Kannt’s major contribution lies in demonstrating, for the first time, the direct association between serum carnosinase concentration and activity with renal function impairment in a type-2 diabetes cohort—a pivotal finding that moves beyond earlier genetic studies linking CN1 polymorphisms to DKD. This work, published in 2022 and already garnering 8 citations, establishes CN1 as a promising diagnostic and prognostic marker for DKD, offering a potential new avenue for early detection and intervention. Kannt’s research is notable for its translational impact, providing a clear enzymatic link between carnosinase activity and kidney health in diabetic patients. For students and researchers, his work exemplifies how integrating molecular enzymology with clinical cohort studies can uncover novel biomarkers, advancing our understanding of diabetes complications and opening doors to targeted therapies.
Research Focus
Key Achievements
Top Papers
- 1